Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1997;75(5):477–489.

Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.

A D Harries 1, D Maher 1, P Nunn 1
PMCID: PMC2487014  PMID: 9447782

Abstract

With the global upsurge in tuberculosis (TB), fueled by the human immunodeficiency virus (HIV) pandemic, and the increase in multidrug-resistant TB, the condition has become a serious occupational hazard for health care workers worldwide. Much of the current understanding about nosocomial TB transmission stems from the USA; however, little is known about the risk of such transmission in low-income countries. The focus of this review is on sub-Saharan Africa, since this is the region with the highest TB incidence, the highest HIV incidence, the worst epidemic of HIV-related TB, and where the risk to health care workers is probably greatest. Measures used in industralized countries to control nosocomial TB transmission (ventilation systems, isolation rooms, personal protective equipment) are beyond the resources of low-income countries. Protecting health care workers in these settings involves practical measures relating to diagnosis and treatment of infectious cases; appropriate environmental control; and relevant personal protection and surveillance of health care workers. Research needs to be carried out to examine the feasibility and cost-effectiveness of measures such as voluntary HIV-testing of health care workers (to enable known HIV-positive health care workers to avoid high-risk settings) and isoniazid preventive therapy for workers in high-risk settings. More resources are also needed to ensure full implementation of currently recommended measures to decrease the risk of nosocomial and laboratory-acquired TB.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adal K. A., Anglim A. M., Palumbo C. L., Titus M. G., Coyner B. J., Farr B. M. The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis. A cost-effectiveness analysis. N Engl J Med. 1994 Jul 21;331(3):169–173. doi: 10.1056/NEJM199407213310306. [DOI] [PubMed] [Google Scholar]
  2. Aisu T., Raviglione M. C., van Praag E., Eriki P., Narain J. P., Barugahare L., Tembo G., McFarland D., Engwau F. A. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS. 1995 Mar;9(3):267–273. [PubMed] [Google Scholar]
  3. Alland D., Kalkut G. E., Moss A. R., McAdam R. A., Hahn J. A., Bosworth W., Drucker E., Bloom B. R. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994 Jun 16;330(24):1710–1716. doi: 10.1056/NEJM199406163302403. [DOI] [PubMed] [Google Scholar]
  4. Allen B. W., Darrell J. H. Contamination of specimen container surfaces during sputum collection. J Clin Pathol. 1983 Apr;36(4):479–481. doi: 10.1136/jcp.36.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beck-Sagué C., Dooley S. W., Hutton M. D., Otten J., Breeden A., Crawford J. T., Pitchenik A. E., Woodley C., Cauthen G., Jarvis W. R. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA. 1992 Sep 9;268(10):1280–1286. doi: 10.1001/jama.1992.03490100078031. [DOI] [PubMed] [Google Scholar]
  6. Braun M. M., Kilburn J. O., Smithwick R. W., Coulibaly I. M., Coulibaly D., Silcox V. A., Gnaore E., Adjorlolo G., De Cock K. M. HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte d'Ivoire. AIDS. 1992 Nov;6(11):1327–1330. doi: 10.1097/00002030-199211000-00014. [DOI] [PubMed] [Google Scholar]
  7. Brindle R. J., Nunn P. P., Githui W., Allen B. W., Gathua S., Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis. 1993 Apr;147(4):958–961. doi: 10.1164/ajrccm/147.4.958. [DOI] [PubMed] [Google Scholar]
  8. Buvé A., Foaster S. D., Mbwili C., Mungo E., Tollenare N., Zeko M. Mortality among female nurses in the face of the AIDS epidemic: a pilot study in Zambia. AIDS. 1994 Mar;8(3):396–396. doi: 10.1097/00002030-199403000-00023. [DOI] [PubMed] [Google Scholar]
  9. Centers for Disease Control and Prevention (CDC) Expanded tuberculosis surveillance and tuberculosis morbidity--United States, 1993. MMWR Morb Mortal Wkly Rep. 1994 May 27;43(20):361–366. [PubMed] [Google Scholar]
  10. Chen C. C., Willeke K. Aerosol penetration through surgical masks. Am J Infect Control. 1992 Aug;20(4):177–184. doi: 10.1016/s0196-6553(05)80143-9. [DOI] [PubMed] [Google Scholar]
  11. Chum H. J., O'Brien R. J., Chonde T. M., Graf P., Rieder H. L. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS. 1996 Mar;10(3):299–309. doi: 10.1097/00002030-199603000-00009. [DOI] [PubMed] [Google Scholar]
  12. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  13. Death by denial. Lancet. 1995 Jun 17;345(8964):1519–1520. [PubMed] [Google Scholar]
  14. Di Perri G., Cruciani M., Danzi M. C., Luzzati R., De Checchi G., Malena M., Pizzighella S., Mazzi R., Solbiati M., Concia E. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989 Dec 23;2(8678-8679):1502–1504. [PubMed] [Google Scholar]
  15. Dolin P. J., Raviglione M. C., Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72(2):213–220. [PMC free article] [PubMed] [Google Scholar]
  16. Dooley S. W., Jr, Castro K. G., Hutton M. D., Mullan R. J., Polder J. A., Snider D. E., Jr Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recomm Rep. 1990 Dec 7;39(RR-17):1–29. [PubMed] [Google Scholar]
  17. Edlin B. R., Tokars J. I., Grieco M. H., Crawford J. T., Williams J., Sordillo E. M., Ong K. R., Kilburn J. O., Dooley S. W., Castro K. G. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992 Jun 4;326(23):1514–1521. doi: 10.1056/NEJM199206043262302. [DOI] [PubMed] [Google Scholar]
  18. Fine P. E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995 Nov 18;346(8986):1339–1345. doi: 10.1016/s0140-6736(95)92348-9. [DOI] [PubMed] [Google Scholar]
  19. Fischl M. A., Uttamchandani R. B., Daikos G. L., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Lai S. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177–183. doi: 10.7326/0003-4819-117-3-177. [DOI] [PubMed] [Google Scholar]
  20. Gebre N., Karlsson U., Jönsson G., Macaden R., Wolde A., Assefa A., Miörner H. Improved microscopical diagnosis of pulmonary tuberculosis in developing countries. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):191–193. doi: 10.1016/0035-9203(95)90491-3. [DOI] [PubMed] [Google Scholar]
  21. Gibson J. Drug-resistant tuberculosis in Sierra Leone. Tubercle. 1986 Jun;67(2):119–124. doi: 10.1016/0041-3879(86)90005-x. [DOI] [PubMed] [Google Scholar]
  22. Glynn J. R., Jenkins P. A., Fine P. E., Pönnighaus J. M., Sterne J. A., Mkandwire P. K., Nyasulu S., Bliss L., Warndorff D. K. Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi. Lancet. 1995 Apr 8;345(8954):907–910. doi: 10.1016/s0140-6736(95)90016-0. [DOI] [PubMed] [Google Scholar]
  23. Griffith D. E., Hardeman J. L., Zhang Y., Wallace R. J., Mazurek G. H. Tuberculosis outbreak among healthcare workers in a community hospital. Am J Respir Crit Care Med. 1995 Aug;152(2):808–811. doi: 10.1164/ajrccm.152.2.7633747. [DOI] [PubMed] [Google Scholar]
  24. Harries A. D., Kamenya A., Namarika D., Msolomba I. W., Salaniponi F. M., Nyangulu D. S., Nunn P. Delays in diagnosis and treatment of smear-positive tuberculosis and the incidence of tuberculosis in hospital nurses in Blantyre, Malawi. Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):15–17. doi: 10.1016/s0035-9203(97)90376-x. [DOI] [PubMed] [Google Scholar]
  25. Harries A. D., Kamenya A., Subramanyam V. R., Salaniponi F. M., Nyangulu D. S. Sputum smears for diagnosis of smear-positive pulmonary tuberculosis. Lancet. 1996 Mar 23;347(9004):834–835. doi: 10.1016/s0140-6736(96)90915-0. [DOI] [PubMed] [Google Scholar]
  26. Harries A. D., Mvula B. The changing pattern of mortality in an African medical ward. Trop Geogr Med. 1995;47(4):171–174. [PubMed] [Google Scholar]
  27. Kenyon T. A., Valway S. E., Ihle W. W., Onorato I. M., Castro K. G. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med. 1996 Apr 11;334(15):933–938. doi: 10.1056/NEJM199604113341501. [DOI] [PubMed] [Google Scholar]
  28. Kopanoff D. E., Snider D. E., Jr, Caras G. J. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis. 1978 Jun;117(6):991–1001. doi: 10.1164/arrd.1978.117.6.991. [DOI] [PubMed] [Google Scholar]
  29. Lallemant-Le Coeur S., Lallemant M., Cheynier D., Nzingoula S., Drucker J., Larouze B. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers. AIDS. 1991 Feb;5(2):195–199. doi: 10.1097/00002030-199102000-00010. [DOI] [PubMed] [Google Scholar]
  30. MIKOL E. X., HORTON R., LINCOLN N. S., STOKES A. M. Incidence of pulmonary tuberculosis among employees of tuberculosis hospitals. Am Rev Tuberc. 1952 Jul;66(1):16–27. doi: 10.1164/art.1952.66.1.16. [DOI] [PubMed] [Google Scholar]
  31. Menzies D., Fanning A., Yuan L., Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995 Jan 12;332(2):92–98. doi: 10.1056/NEJM199501123320206. [DOI] [PubMed] [Google Scholar]
  32. Mukadi Y., Perriëns J. H., St Louis M. E., Brown C., Prignot J., Willame J. C., Pouthier F., Kaboto M., Ryder R. W., Portaels F. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet. 1993 Jul 17;342(8864):143–146. doi: 10.1016/0140-6736(93)91346-n. [DOI] [PubMed] [Google Scholar]
  33. Mulder D. W., Nunn A. J., Kamali A., Nakiyingi J., Wagner H. U., Kengeya-Kayondo J. F. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet. 1994 Apr 23;343(8904):1021–1023. doi: 10.1016/s0140-6736(94)90133-3. [DOI] [PubMed] [Google Scholar]
  34. Nettleman M. D., Fredrickson M., Good N. L., Hunter S. A. Tuberculosis control strategies: the cost of particulate respirators. Ann Intern Med. 1994 Jul 1;121(1):37–40. doi: 10.7326/0003-4819-121-1-199407010-00007. [DOI] [PubMed] [Google Scholar]
  35. Pape J. W., Jean S. S., Ho J. L., Hafner A., Johnson W. D., Jr Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993 Jul 31;342(8866):268–272. doi: 10.1016/0140-6736(93)91817-6. [DOI] [PubMed] [Google Scholar]
  36. Peerbooms P. G., van Doornum G. J., van Deutekom H., Coutinho R. A., van Soolingen D. Laboratory-acquired tuberculosis. Lancet. 1995 May 20;345(8960):1311–1312. doi: 10.1016/s0140-6736(95)90962-1. [DOI] [PubMed] [Google Scholar]
  37. Perriëns J. H., St Louis M. E., Mukadi Y. B., Brown C., Prignot J., Pouthier F., Portaels F., Willame J. C., Mandala J. K., Kaboto M. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med. 1995 Mar 23;332(12):779–784. doi: 10.1056/NEJM199503233321204. [DOI] [PubMed] [Google Scholar]
  38. Pike R. M. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu Rev Microbiol. 1979;33:41–66. doi: 10.1146/annurev.mi.33.100179.000353. [DOI] [PubMed] [Google Scholar]
  39. Riley R. L., Knight M., Middlebrook G. Ultraviolet susceptibility of BCG and virulent tubercle bacilli. Am Rev Respir Dis. 1976 Apr;113(4):413–418. doi: 10.1164/arrd.1976.113.4.413. [DOI] [PubMed] [Google Scholar]
  40. Small P. M., Hopewell P. C., Singh S. P., Paz A., Parsonnet J., Ruston D. C., Schecter G. F., Daley C. L., Schoolnik G. K. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994 Jun 16;330(24):1703–1709. doi: 10.1056/NEJM199406163302402. [DOI] [PubMed] [Google Scholar]
  41. Sudre P., ten Dam G., Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992;70(2):149–159. [PMC free article] [PubMed] [Google Scholar]
  42. Sugita M., Tsutsumi Y., Suchi M., Kasuga H., Ishiko T. Pulmonary tuberculosis. An occupational hazard for pathologists and pathology technicians in Japan. Acta Pathol Jpn. 1990 Feb;40(2):116–127. doi: 10.1111/j.1440-1827.1990.tb01550.x. [DOI] [PubMed] [Google Scholar]
  43. Tembo G., Friesan H., Asiimwe-Okiror G., Moser R., Naamara W., Bakyaita N., Musinguzi J. Bed occupancy due to HIV/AIDS in an urban hospital medical ward in Uganda. AIDS. 1994 Aug;8(8):1169–1171. doi: 10.1097/00002030-199408000-00021. [DOI] [PubMed] [Google Scholar]
  44. Weltman A. C., Rose D. N. The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS. 1993 Feb;7(2):149–157. doi: 10.1097/00002030-199302000-00001. [DOI] [PubMed] [Google Scholar]
  45. Wenger P. N., Otten J., Breeden A., Orfas D., Beck-Sague C. M., Jarvis W. R. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients. Lancet. 1995 Jan 28;345(8944):235–240. doi: 10.1016/s0140-6736(95)90228-7. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES